[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100451579":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":30,"locations":37,"responsibleParty":55,"collaborators":19,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":19,"eligibilityCriteria":63,"healthyVolunteers":64,"sex":65,"minAge":66,"maxAge":67,"enrollmentInfo":68,"targetDuration":19,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":77,"overallStatus":40,"whyStopped":19,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"Firalis SA","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Healthy Volunteers","OTHER","Healthy Volunteers will be recruited into the study",[13],"Diagnostic Test: Biomarker based IVD tests",[15],{"type":16,"name":17,"description":17,"armGroupLabels":18,"otherNames":19},"DIAGNOSTIC_TEST","Biomarker based IVD tests",[9],null,[21,24,27],{"name":22,"affiliation":5,"role":23},"Pierre Rohrlich, MD,Phd","PRINCIPAL_INVESTIGATOR",{"name":25,"affiliation":5,"role":26},"Hueseyin Firat, MD, PhD, HDR","STUDY_DIRECTOR",{"name":28,"affiliation":5,"role":29},"Stephanie Boutillier, PhD","STUDY_CHAIR",[31,36],{"name":32,"role":33,"phone":34,"phoneExt":19,"email":35},"Federica ZILLI, PhD","CONTACT","0389911320","clinical@firalis.com",{"name":25,"role":33,"phone":34,"phoneExt":19,"email":35},[38],{"facility":39,"status":40,"city":41,"state":19,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Firalis Clinical Investigation Center","RECRUITING","Huningue","68330","France","FR",{"type":46,"coordinates":47},"Point",[48,49],7.57782,47.60477,{"lat":49,"lon":48},[52],{"name":53,"role":33,"phone":34,"phoneExt":19,"email":54},"Federica Zilli, PhD","federica.zilli@firalis.com",{"type":56,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100451579","validation-of-the-stability-of-diagnostic-biomarkers-on-healthy-volunteers-100451579",false,"NCT05160337","Validation of the Stability of Diagnostic Biomarkers on Healthy Volunteers","Clinical Study on Healthy Volunteers for Validating the Stability of Different Diagnostic Biomarkers Studied at Firalis","Inclusion Criteria:\n\n* Participants who sign the informed consent forms for sample collection and data collection both anonymized and reported in CRF.\n* Able to comply with all study procedures.\n* Healthy Volunteers having no apparent disease.\n* Adults, both genders, aged 18-85 years.\n* Participants with no apparent motor or mental health abnormality.\n* Participants having no major disabling mental or physical disability that would require hospitalization.\n* Body weight above 50 kg if male, above 40 kg if female.\n\nExclusion Criteria:\n\n* Any subject who did not sign the Informed Consent form.\n* Any subject who, in the judgment of the Investigator, is likely to be non-compliant during the study, or unable to cooperate because of a language problem or poor mental development.\n* Any subject in the exclusion period of a previous study according to applicable regulations.\n* Any subject who cannot be contacted in case of emergency.\n* Any subject who is the Investigator or any sub-investigator, research assistant, study coordinator, or other staff thereof, directly involved in the conduct of the protocol.\n* Any subject with a disease that, in the judgement of the investigator, would interfere with the conduct of study or harm the safety of volunteer.\n* Subjects with disabling disease or abnormal health status are excluded.\n* Subjects aged below 18 years and older than 85 years are excluded.\n* Pregnant, parturient and nursing women are excluded.\n* Subjects deprived of their liberty by a judicial or administrative decision, protected adults and vulnerable persons are excluded.\n* Subjects who are under legal protection or who are unable to express their consent are not included.\n* Any subject who reports in the questionnaire of the screening period having one of the following diseases is excluded:\n\n  * Any psychiatric or neurodegenerative disease or neurologic disorder.\n  * Hypertension.\n  * Any cardiovascular disease.\n  * Any chronic inflammatory disease such as rheumatoid arthritis.\n  * Any cancer.\n  * Frequent headaches and\u002For migraine, recurrent nausea and\u002For vomiting.\n* Any subject who did a blood donation, any volume, within 2 months before inclusion.\n* Any subject who reports in the questionnaire of the screening period having medication(s) for one or more of the above diseases is excluded.\n* Drug or alcohol abuse or smoking more than 10 cigarettes or equivalent.\n* Subjects with no apparent disease and symptoms, but with unknown Covid-19 positivity are not excluded.",true,"ALL","18 Years","85 Years",{"count":69,"type":70},60,"ESTIMATED","INTERVENTIONAL",[73],"NA","Stability studies on the peripheral biomarkers (lncRNAs, sncRNAs, mRNAs, proteins, lipids\u002Fmetabolites) measured by Firalis IVD test candidates and effect of gender, age, nutrition on their expression level",[76],"Healthy",[78,79,80,81],"biomarkers","chronobiology","healthy volounteers","diagnostic biomarkers","2026-06-22",{"date":84,"type":85},"2026-06-24","ACTUAL",{"date":87,"type":85},"2025-06-18",{"date":89,"type":70},"2027-04",{"name":5,"class":6},1]